Comparison of Two Spinal Needles Regarding Postdural Puncture Headache
Postdural Puncture Headache After Spinal Anesthesia for Cesarean Section, Two Different Needles.
The aim of the study is to observe the rate of postdural puncture headache observed after spinal anesthesia in cesarean section patients.
Two kind of spinal anesthesia needles will be used:
- 26 Gauge Quincke (cutting-tip needle)
- 26 Gauge Atraucan (atraumatic needle)
The investigators will observe:
- Number of spinal punctures
- Time required for the spinal anesthesia procedure
Patients will be evaluated after 7 days for:
- Headache
- Backache
Aperçu de l'étude
Statut
Description détaillée
It is a known phenomenon that spinal anesthesia sometimes results in headache.
The aim of the study is to observe the rate of postdural puncture headache observed after spinal anesthesia in cesarean section patients.
Two kind of spinal anesthesia needles will be used:
- 26 Gauge Quincke (cutting-tip needle)
- 26 Gauge Atraucan (atraumatic needle)
We will observe:
- Number of spinal punctures
- Time required for the spinal anesthesia procedure
Patients will be evaluated after 7 days for:
- Headache
- Backache
2 kind of spinal anesthesia needles will be used, but no comparison will be made. This is an observational study. Although literature gives different rates of postdural puncture headache for these two needles, we observe the same rate of headache in our clinical practice. We want to define the real rate of postdural puncture headache in patients undergoing cesarean section with spinal anesthesia.
Type d'étude
Inscription (Réel)
Contacts et emplacements
Lieux d'étude
-
-
-
Adiyaman, Turquie
- Adiyaman University Research Hospital
-
-
Critères de participation
Critère d'éligibilité
Âges éligibles pour étudier
Accepte les volontaires sains
Sexes éligibles pour l'étude
Méthode d'échantillonnage
Population étudiée
La description
Inclusion Criteria:
- Pregnant female patients between 18-40 years old undergoing cesarean section
- Patient accepting spinal anesthesia
Exclusion Criteria:
- Infection at the spinal needle insertion cite
- Coagulability disorder
- Patient not accepting the procedure
Plan d'étude
Comment l'étude est-elle conçue ?
Détails de conception
Cohortes et interventions
Groupe / Cohorte |
|---|
|
26 gauge quincke
Patients (n=150) will be treated with 26 gauge quincke spinal needle for spinal anesthesia for cesarean section.
|
|
26 gauge atraucan
Patients (n=110) will be treated with 26 gauge atraucan spinal needle for spinal anesthesia for cesarean section.
|
Que mesure l'étude ?
Principaux critères de jugement
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Postdural Puncture Headache in Patients Receiving Spinal Anesthesia for Cesarean Section
Délai: 1 week
|
Patients were observer for the symptoms of headache (PDPH) for 1 week.
On the 1st postoperative day they were visited in the clinic.
On the 7th postoperative day they were contacted by telephone and were asked about the symptoms.
|
1 week
|
Mesures de résultats secondaires
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Backache in Patients Receiving Spinal Anesthesia for Cesarean Section
Délai: 1 week
|
Patients were observer for the symptoms of postdural puncture backache for 1 week.
On the 1st postoperative day they were visited in the clinic.
On the 7th postoperative day they were contacted by telephone and were asked about the symptoms.
|
1 week
|
Collaborateurs et enquêteurs
Parrainer
Les enquêteurs
- Chercheur principal: Ruslan Abdullayev, Adiyaman University Research Hospital, Department of Anesthesiology and Reanimation
Dates d'enregistrement des études
Dates principales de l'étude
Début de l'étude
Achèvement primaire (Réel)
Achèvement de l'étude (Réel)
Dates d'inscription aux études
Première soumission
Première soumission répondant aux critères de contrôle qualité
Première publication (Estimation)
Mises à jour des dossiers d'étude
Dernière mise à jour publiée (Estimation)
Dernière mise à jour soumise répondant aux critères de contrôle qualité
Dernière vérification
Plus d'information
Termes liés à cette étude
Termes MeSH pertinents supplémentaires
Autres numéros d'identification d'étude
- PDPH 26Q26A
Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .